DIRS.INFO The most relevant business & tech news

☆ Oprah Winfrey apologizes for being 'major contributor' to shaming diet culture and the 'wagon of fat' moment
▼ + stars: | 2024-05-11 | by ( Eve Crosbie | ) www.businessinsider.com time to read: +4 min

"I've been a steadfast participant in this diet culture. AdvertisementIn 1988, Oprah Winfrey appeared on her show pulling a wagon full of fat, representing the 67 pounds she had lost in four months. Now, Winfrey told the audience that she wants to support them in their shift toward self-acceptance and healthier mindsets. Oprah Winfrey discussed her history with weight loss culture during the three-hour live stream from Weight Watchers. Shortly after, the Oscar winner helmed the ABC televised special "Shame, Blame and the Weight Loss Revolution," which saw her discuss the growing popularity of weight loss drugs such as Ozempic, Mounjaro, and Wegovy.

Persons: —, Oprah Winfrey, Winfrey, I've, makeovers, We've, Sima Sistani Organizations: Service, Business, WW International, National Museum of, WeightWatchers, ABC

☆ Oprah Winfrey: I set an unrealistic standard for dieting
▼ + stars: | 2024-05-09 | by ( Nicole Goodkind | ) edition.cnn.com time to read: +4 min

New York CNN —Oprah Winfrey said on Thursday evening that she has long played a role in promoting unhealthy and unrealistic diets. I cannot tell you how many weight loss shows and makeovers I have done and they have been a staple since I’ve been working in television,” she said. Winfrey told People Magazine in December that she has added a “weight-loss medication to her regimen” but didn’t specify which drug. Winfrey and WeightWatchersWinfrey left the board of WeightWatchers, ending a nearly decade-long stint as a director of the beleaguered company, in February. “I will say that I was on the board at the time there were discussions about whether or not WeightWatchers would move into weight loss medications,” Winfrey said on Thursday.

Persons: Oprah Winfrey, ”, I’ve, makeovers, Winfrey, Rebel Wilson, Amber Riley, Sima Sistani, Sistani, WeightWatchers Winfrey, ” Winfrey, Oprah, WeightWatchers, ” WeightWatchers, Jimmy Kimmel, “ Organizations: New, New York CNN, YouTube, WeightWatchers, Magazine, National Museum of, Goldman Sachs Locations: New York

☆ WeightWatchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
▼ + stars: | 2024-03-14 | by ( Eric Rosenbaum | ) www.cnbc.com time to read: +6 min

But since then WW shares have suffered heavy selling, dropping to a new 52-week low on Thursday. The stock, due to its debt load and short interest, as well as the general anxiety about the impact of the new weight loss drugs, is subject to heightened volatility. In the memo, Sistani told employees she wanted "to take a moment to address some of the breathless media coverage." WW shares closed at $1.87 on Thursday. It noted that WW was among companies from the weight loss industry involved in the TV event.

Persons: Oprah Winfrey, Sistani, Eli Lilly, Sima Sistani, Guggenheim, Oprah, Winfrey Organizations: CNBC, Nordisk, Guggenheim Partners, Guggenheim, WeightWatchers Clinic, FDA, WeightWatchers, National Museum of, ABC

☆ Oprah is leaving WeightWatchers’ board, sending stock tumbling 25%
▼ + stars: | 2024-02-29 | by ( Jordan Valinsky | ) edition.cnn.com time to read: +2 min

New York CNN —Oprah Winfrey is leaving the board of WeightWatchers, ending a nearly decade-long stint as a director of the beleaguered company that has faced sudden competition from Ozempic. WeightWatchers shares (WW) plunged 25% in premarket trading Thursday and would be down 85% for the past six months if the premarket losses hold. WeightWatchers has faced more competition recently from GLP-1 prescriptions drugs like Ozempic and Wegovy sometimes used for weight loss. Last year, WeightWatchers also made a $100 million-plus deal to buy Sequence, a telehealth business that offers virtual prescriptions to patients for these weight loss drugs where appropriate. Winfrey told People Magazine in December that she has added a “weight-loss medication to her regimen” but didn’t specify which drug.

Persons: Oprah Winfrey, Winfrey, ”, Oprah, Sima Sistani, WeightWatchers, ” Winfrey Organizations: New, New York CNN, Ozempic, National Museum of, WeightWatchers, Magazine Locations: New York, GLP

☆ Thinking about taking new weight loss drugs? These are the big health risk decisions that will follow
▼ + stars: | 2024-02-28 | by ( Eric Rosenbaum | ) www.cnbc.com time to read: +6 min

In this article NOVO.B-DKLLYWWGWW Follow your favorite stocks CREATE FREE ACCOUNTAn injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. But will Americans trust the most iconic brand in the legacy weight-loss business to guide them into its future? "Big pharma was coming for weight loss, and if they didn't have a clinical angle, they would have run the risk of becoming an irrelevant company." "This is a new, incredibly powerful and effective class of pharmaceuticals that a lot of people will find help improve their health." watch nowRisks of overreliance on obesity drugs The risk is real that providers may use the medications and "forget about lifestyle," said John Batsis, an associate professor and nutrition expert at the University of North Carolina Chapel Hill's school of public health.

Persons: Eli Lilly’s, Brendan Mcdermid, Eli Lilly, —, Sima Sistani —, Sistani, Alex Fuhrman, Hallum, Fuhrman, Davidson, Linda Bolton Weiser, I've, Geoff Cook, Cook, John Batsis, Batsis Organizations: Reuters, Novo Nordisk, CNBC, Craig, pharma, University of North, University of North Carolina Chapel Locations: New York City, U.S, Herbalife, University of North Carolina

☆ How to access the new weight loss drugs
▼ + stars: | 2024-02-15 | by ( Andrea Kane | ) edition.cnn.com time to read: +7 min

(CNN) — By now, it is pretty clear that the new weight loss and diabetes medications have achieved blockbuster status. Unlike previous weight loss medications, they are pretty effective at helping people lose weight and keep it off — between around 15% to 20% of body weight — with relatively few side effects (although some people can’t tolerate them, and a fraction of patients experience more severe side effects). Zepbound, the newly approved weight loss drug from Eli Lilly, may be easier to find. “Otherwise, some physicians are prescribing older, generic weight loss medications that can be helpful for some patients.”These drugs are not right for everyoneFor many people, the cultural pressure to look a certain way is high. And join us next week on the Chasing Life podcast when we talk to WeightWatchers CEO Sima Sistani about whether these new weight loss drugs really signal the end of diet culture.

Persons: Sanjay Gupta ”, Eli Lilly, Goldman Sachs, Meg Tirrell John Nowak “, Meg Tirrell, Sanjay Gupta, ” Tirrell, “, ” Eli Lilly, Tirrell, ”, Sima Sistani Organizations: CNN, —, Trilliant Health, Novo Nordisk, US Food and Drug Administration, “, Nordisk, ”

☆ 3 titans will fight to dominate the market for Wegovy in 2024
▼ + stars: | 2023-12-27 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +5 min

Dozens of startups have jumped into the weight-loss market this year as weight-loss drugs, including Wegovy and Ozempic, have exploded in popularity. The few companies with enough money and brand recognition to stand up to Ozempic's distribution challenges — WeightWatchers, Noom, and Ro — can expect to compete for market dominance next year. But WeightWatchers signaled it's going all in on weight-loss drugs by launching its own behavioral program for patients on Ozempic in December. WeightWatchersLike WeightWatchers, Noom has remained staunchly in the weight-loss market since its 2008 launch. Ro launched its own program prescribing weight-loss drugs in January.

Persons: VCs, — WeightWatchers, Sari Kaganoff, WeightWatchers, it's, Sima Sistani, Noom, Ro, Zach Reitano, Kaganoff, Saeju Jeong, Sam Barnes, Aaron DeGagne Organizations: Business, Rock Health, Web, Getty, PitchBook Locations: Ozempic

☆ Sima Sistani says its time for WeightWatchers to embrace Ozempic. Will its users agree?
▼ + stars: | 2023-11-28 | by ( Nicole Goodkind | ) edition.cnn.com time to read: +10 min

Sima Sistani, the 44-year-old CEO of WeightWatchers, is aware of this, and she recognized WeightWatchers had to evolve – or else. She also landed a massive deal to buy a telehealth business that can issue virtual prescriptions to patients for these weight loss drugs. Semaglutide was approved by the US Food and Drug Administration to treat type 2 diabetes as Ozempic, but it was also used off-label for weight loss. Some longtime users of the program feel betrayed by the pivot away from in-person meetings and toward medication-based solutions. “Sadly, they don’t want to do the work,” she said, of tracking food or exercising to achieve weight loss goals.

Persons: New York CNN —, Sima Sistani, WeightWatchers, she’s, Sistani, “, ” Sistani, Erica Shroeder, ”, Jaap Arriens, ” Goldman Sachs, Jenny Craig, Adam Rockmore, Ged, Angela Weiss, Variety Sistani, there’s, Semaglutide, aren’t, “ there’s, Oprah Winfrey, Jamie Yonash, influencers, Velanti, Michael Nagle, We’re Organizations: New, New York CNN, Walmart, CNN, WeightWatchers, Variety, US Food and Drug Administration, Bloomberg, Getty Locations: New York, Cola, Wegovy

☆ The Ozempic effect has battered this weight loss stock, but Morgan Stanley says it's a top pick
▼ + stars: | 2023-11-03 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +4 min

Sequence gives subscribers access to GLP-1 medications such as Novo Nordisk's Wegovy and Ozempic. Schenk said the concern about the drop in WW's average revenue per user "seems overblown" and has created a buying opportunity for the stock. Stabilizing core business WW has been focused on stabilizing its core weight loss business. Both developments are a positive for WW's Sequence business. Schenk estimates that around 6 million current or lapsed WW subscribers would qualify for treatment with obesity medication.

Persons: Sima Sistani, Morgan Stanley, Lauren Schenk, Eli Lilly, Schenk, Lilly, Novo Organizations: International, Nordisk's Wegovy, FDA, 3Q, and Drug Administration, Novo Nordisk Locations: Friday's, Novo

☆ US troops attacked in Iraq, Syria and on alert for more strikes
▼ + stars: | 2023-10-19 | by ( Idrees Ali | Thomson Reuters | National Security Correspondent Focusing On The Pentagon In Washington D.C. Reports On U.S. Military Activity | ) www.reuters.com time to read: +3 min

On Wednesday, a drone hit U.S. forces in Syria resulting in minor injuries, while another one was brought down. Earlier this week, U.S. forces thwarted multiple drones targeting troops in Iraq. At least 3,785 Palestinians have been killed and 12,493 wounded in Israeli strikes on Gaza, the health ministry in Gaza said. In past years, Iranian-backed militias in Iraq regularly targeted U.S. forces in Iraq and the U.S. embassy in Baghdad with rockets. Such attacks had abated under a truce in place since last year, and Iraq has had a period of relative calm.

Persons: Alaa, Joe Biden, Al, Asad, I'm, Patrick Ryder, Ryder, Ali al, Israel, Idrees Ali, Grant McCool Organizations: U.S, Islamic, REUTERS, Rights, Pentagon, U.S . Navy, Thursday, ISRAEL, Gaza, United, Hezbollah, Thomson Locations: Makhmour, Mosul, Iraq, Syria, Washington, Iran, Israel, U.S, Al Asad, Yemen, Gaza, United States, State, Baghdad

☆ U.S. says it thwarted drone attack on its troops in Iraq
▼ + stars: | 2023-10-18 | by ( ) www.reuters.com time to read: +4 min

TEL AVIV, Oct 18 (Reuters) - The U.S. military thwarted an attack targeting its forces in Iraq early on Wednesday, intercepting two drones before they could strike, two U.S. officials said after the first such attack on U.S. forces in Iraq in more than a year. The one-way attack drones were intercepted as they attempted to strike Iraq's al Asad air base, which hosts American troops, the officials said. Last week he threatened to target U.S. interests if Washington intervened to support Israel. Dozens of members of the Popular Mobilisation Forces (PMF), the state paramilitary organisation that contains many Iran-backed factions, took to the streets on Tuesday to condemn the hospital attack. Demonstrators chanted anti-U.S. and anti-Israeli slogans and said they wanted to storm the U.S. embassy for its support of Israel.

Persons: Iraq's al Asad, Joe Biden, Israel, Ali al, Hadi Al, Amiri, Washington, Kataib, Phil Stewart, Amina Ismail, Ahmed Rasheed, Ahmed Saad, Clarence Fernandez, Nick Macfie Organizations: U.S, Reuters, American, Hamas, Islamic, Israel, Hezbollah, United, Popular, Forces, ., Thomson Locations: TEL AVIV, Iraq, U.S, Washington, Iran, Israel, Gaza, Al, Ahli, Israeli, United States, Iraqi, Badr, America, Syria, State, Baghdad, Tel Aviv, Erbil

☆ The Company That Defined Dieting Is Sorry It Told Us to Have More Willpower
▼ + stars: | 2023-10-07 | by ( Erich Schwartzel | ) www.wsj.com time to read: 1 min

WeightWatchers Chief Executive Sima Sistani hears from them all of the time, those customers she thinks her company has failed. They fill her Instagram inbox with messages detailing their years on the WeightWatchers count-your-points program, a frustrating pattern of fluctuating weight that only made them feel like they weren’t trying hard enough.

Persons: Sima Sistani

☆ This is the first time in WW history that Q2 ended higher than Q1, says CEO Sima Sistani
▼ + stars: | 2023-08-16 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThis is the first time in WW history that Q2 ended higher than Q1, says CEO Sima SistaniSima Sistani, WW International CEO, joins 'Closing Bell Overtime' to talk weight loss drugs, growth in WW's digital platforms and the stock's reaction.

Persons: Sima Sistani Sima Sistani Organizations: WW International

☆ WeightWatchers could either win big or lose faithful customers, or both, in its pivot to Ozempic trend
▼ + stars: | 2023-07-22 | by ( Jordan Hart | ) www.businessinsider.com time to read: +3 min

Sequence offers access to weight-loss drugs like Ozempic and Wegovy. Analysts say the move could save the company, but some WeightWatchers members aren't happy. Although the medication has gained popularity online and among celebrities, veteran WeightWatchers members aren't all happy with the company's pivot. Some WeightWatchers members expressed concern that the company was abandoning its message of self-restraint for the easy solution of weight-loss medication. Sequence, meanwhile, prescribes weight-loss medications like Ozempic and Wegovy and helps patients afford the drugs through insurance and reimbursements.

Persons: WeightWatchers, aren't, They're, Goldman Sachs, Sima Sistani, Jenny Craig Organizations: WW, Inc, Bloomberg, Employers

CNN —Dissident Iranian rapper Toomaj Salehi, arrested last October for supporting the protest movement in Iran last year, has been sentenced to six years and three months in prison, his official Twitter page said Monday. “Toomaj Salehi was sentenced to 6 years and 3 months in prison, and after 252 days of solitary confinement, transferred to the general section of the prison,” the tweet said. Salehi was arrested in October last year during protests triggered by the death of Mahsa Amini. Toomaj/Youtube“Your Toomaj, Iran’s Toomaj, the world’s Toomaj, and our Toomaj was unjustly imprisoned for six and a half years. When nationwide protests started in mid-September last year, Salehi called for Iranians to protest against the government.

Persons: Toomaj Salehi, “ Toomaj Salehi, IRNA, Reza Etemad Ansari, “, ” Ansari, Shargh, ” Salehi’s, Iqbal Iqbali, Salehi, Mahsa, Iran’s Toomaj, ” Iqbali, ” Salehi, ”, jang Organizations: CNN, Dissident, Twitter, Iranian, Kurd Locations: Iran, Sistani

☆ 'Every victim of Saddam Hussein was waiting for this moment'
▼ + stars: | 2023-03-13 | by ( Charlotte Bruneau | ) www.reuters.com time to read: +2 min

[1/5] Ali Hassan al-Haidari, who testified against former Iraqi President Saddam Hussein during the Dujail trial, that led to Saddam's death sentence, sits at his home in Dujail, Iraq, January 28, 2023. "Every victim of Saddam Hussein was waiting for this moment," said Haidari, one of the few people who was ready to show his face when giving testimony to the court that sent the former Iraqi strongman to the gallows. Seven of his brothers were among those killed in the security sweep after the attempt on Saddam's life as his convoy passed by. A video from the trial showed Haidari standing with Saddam behind him and telling the judges: "He is responsible for my detention, for losing my future, for executing my brothers". Grand Ayatollah Ali al-Sistani, Iraq's most influential Shi'tie cleric, issued a religious decree calling on Iraqis to fight against Islamic State.

☆ WeightWatchers stock surges 70% after company agrees to buy obesity treatment platform
▼ + stars: | 2023-03-07 | by ( Rebecca Picciotto | ) www.cnbc.com time to read: +1 min

Shares of WW International , also known as WeightWatchers, skyrocketed Tuesday after the company said it planned to buy Sequence, a telehealth platform that provides treatment for obesity. Shares of the company were down 57% over the past year as it struggled to pivot to wellness and move away from weight loss. Sistani took over as chief executive at the end of February, steering the company back toward weight loss messaging. The Sequence announcement comes as companies across the weight loss industry look to offer obesity medications as a pathway to customers looking to shed pounds. The trend has led to a shortage in medications like Ozempic, which are commonly prescribed for Type 2 diabetes.

☆ WW International CEO on weight loss drugs: Still critical you make the right lifestyle changes
▼ + stars: | 2023-03-07 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWW International CEO on weight loss drugs: Still critical you make the right lifestyle changesCNBC's Meg Tirrell talks with Sima Sistani, WW International CEO, on 'Closing Bell: Overtime' to discuss the company's stock surge after announcing it had acquired Sequence, a telehealth platform that helps treat obesity.

☆ WeightWatchers is buying a company that lets you pay $99 a month to see a doctor on video and get a prescription to popular weight-loss drug Ozempic
▼ + stars: | 2023-03-07 | by ( Lakshmi Varanasi | ) www.businessinsider.com time to read: +4 min

WeightWatchers announced Monday it was buying Sequence, a clinical weight management platform. Members will get Sequence's services including telehealth visits and prescriptions for weight loss drugs like Ozempic. Through Sequence's $99-a-month subscription program, customers can schedule telehealth appointments with doctors who will prescribe weight loss and diabetes management drugs like Ozempic and Wegovy. "As science advances rapidly, we know there is a significant opportunity to improve outcomes for those using medications," WeightWatchers' CEO Sima Sistani said in a press release. Doctors are even adding the hashtags to videos that are about weight loss solutions that don't rely on those medications.

☆ Under threat, Weight Watchers enters obesity drug space. Here's what it means for the stock
▼ + stars: | 2023-03-07 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +7 min

The company's sales have been in a steady multiyear decline after an attempt to de-emphasize weight loss and focus on wellness failed miserably. WW 1Y mountain The parent of Weight Watchers has seen its market value shrink as sales have dropped for several years. Another drug, Eli Lilly's Mounjaro, adds a second incretin hormone to the mix and has been shown to be even more successful with weight loss. This trend could provide an opportunity for the core Weight Watchers brand and its focus on behavior modification. That scenario assumes Weight Watchers continues to see membership erosion, while cost controls help minimize margin compression.

☆ A generation of high-profile women tech leaders have stepped aside. What’s next?
▼ + stars: | 2023-02-24 | by ( Catherine Thorbecke | ) edition.cnn.com time to read: +7 min

The tech industry has now lost an entire generation of trailblazing women leaders and replaced them mostly with men. And in the wake of the pandemic, women leaders in corporate America more broadly are more likely than ever to quit, according to the most recent Women in the Workplace report from McKinsey & Company and LeanIn.Org. Now that she’s departing, Big Tech is facing a new reckoning over its failure to promote and support women leaders, and what this could mean for the next generation of women in the industry. “Without women in the C-suite who have come before them, it could make this transition period tougher for next generation women leaders,” Kray said. “I think that what she achieved and what she modeled will be something that will live on beyond the fact that now we don’t have a female Big Tech CEO.”

Iranian authorities did not respond to requests for comment for this story. His comments have angered Iranian authorities, who placed him under a travel ban in 2017. The supreme leader's office wrote back and said Iran's government does not allow discrimination or inequality. Iranian officials have occasionally counted on him in times of crisis. The group, denounced by Tehran as terrorists, has carried out repeated attacks on Iranian security forces.

Search resuls for: "Sistani"

22 mentions found